https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
39cm vs. 2.7cm; p 0.01). Frequency was similar between males and females (51.7% vs. 48.3%; p 0.0.5). Five- and ten-year OS among all patients was 87% and 84%, respectively. EOR was not associated with survival for any WHO grade. On multivariable analysis, only patient age (p = 0.022), WHO grade (p = 0.003) and medical comorbidity scores (p = 0.002) were independently associated with OS after diagnosis. Patients with CPTs present at different stages of life, with sizable tumor burden and distinct WHO grade prevalen
Like
Comment
Share
